Table 3.
compound | brain | heart | liver | lung |
---|---|---|---|---|
UDP-α-d-Glc | 38.5 ± 1.7 | 13.1 ± 1.7 | 141.4 ± 4.4 | 28.1 ± 0.9 |
UDP-α-d-Gal | 16.7 ± 2.1 | 11.2 ± 2.3 | 79.0 ± 4.2 | 12.9 ± 0.2 |
UDP-α-d-GlcA | 6.1 ± 0.3 | 8.3 ± 1.4 | 10.1 ± 0.7 | 10.8 ± 0.2 |
UDP-α-d-Xyl | 1.7 ± 0.1 | 1.2 ± 0.2 | 9.1 ± 0.4 | 1.3 ± 0.1 |
UDP-β-l-Arap | 0.2 ± 0.0 | 0.03 ± 0.0 | 0.9 ± 0.1 | 0.1 ± 0.0 |
UDP-α-d-GlcNAc/GalNAc | 78.7 ± 4.3 | 62.3 ± 5.3 | 346.6 ± 10.1 | 77.0 ± 3.5 |
GDP-β-l-Fuc | 6.1 ± 0.4 | 3.8 ± 0.5 | 2.3 ± 0.1 | 5.5 ± 0.3 |
GDP-α-d-Man | 18.2 ± 1.6 | 8.3 ± 1.4 | 18.2 ± 1.1 | 10.6 ± 0.4 |
CMP-Neu5Ac | 52.9 ± 1.7 | 27.8 ± 4.3 | 6.9 ± 0.6 | 33.4 ± 1.2 |
PAPS | 0.1 ± 0.0 | 0.1 ± 0.0 | 1.3 ± 0.1 | 0.9 ± 0.0 |
Values are reported as pmol mg−1 fresh weight and represent the average of n = 3 technical replicates ± STDEV.